World Health Organization (WHO) · Journal articles
A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine—pyrimethamine) in Brazilian male subjects
View original document
The full text is hosted by the publishing organisation. lawenc.com indexes the metadata and links to the official source.
Key facts
Organisation
World Health Organization (WHO)
Document type
Journal articles
Source
World Health Organization